Stock Of The Week: Can SAP Stock Continue to Rally?

The German cloud software stock is has taken the crown as Europe’s biggest stock from Novo Nordisk

Christopher Johnson 28 March, 2025 | 9:58AM
Facebook Twitter LinkedIn

 

0 seconds of 0 secondsVolume 90%
Press shift question mark to access a list of keyboard shortcuts
00:00
00:00
00:00
 

Key Takeaways

  • SAP’s share price up almost 40% over one year 
  • SAP has overtaken Novo Nordisk as Europe’s largest company  
  • SAP’s transition to the cloud has driven high returns  
  • SAP is trading below its fair value estimate 

German software giant, SAP, has become the largest stock in Europe, overtaking Ozempic producer Novo Nordisk.

Both AI and cloud revenue have increased, helping to boost valuations.

Just last month Rob Hales, senior equity analyst at Morningstar, raised SAP’s moat to wide from narrow, the fair value estimate for the stock to 265 euros from 150 euros, and improved the stock’s capital allocation rating from poor to standard.

Key Morningstar Metrics for SAP


Is SAP Stock a Buy, Sell or Hold?

Morningstar was previously bearish on the company over concerns about it losing customers.

But with about 80% of SAP’s legacy customers now committed to its upgraded enterprise resource planning system, those fears have now abated.

SAP’s previous management were the reason behind Morningstar’s poor capital allocation rating for the business.

But Hales backs the company’s turnaround story, as SAP is reaping the rewards of its current management’s focus on cloud product development.

So, after such a strong run, are SAP shares now a buy, sell or hold?

Actually, the company is currently undervalued according to Morningstar metrics.

Although shares are up 35% over one year, SAP is trading at 246.45 EUR below Morningstar’s fair value estimate of 265 EUR.

SAP Stock vs. Morningstar Fair Value Estimate

undefined


The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar's editorial policies.

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

About Author

Christopher Johnson  is data journalist at Morningstar

© Copyright 2025 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures